Compound ID | 1359
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Membrane-active agent |
| Target Pathogen: | Active against both multidrug-resistant and susceptible Staphylococcus aureus |
| Description: | A diarylurea derivative |
| Institute where first reported: | R&D Systems, MN |
| Year first mentioned: | 2020 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9549305 |
| Citation: | https://mbio.asm.org/content/11/3/e01140-20 |